Skip to main content

The Pharmacological Bases for the Vascular Impact of Ginkgo Biloba Extract

  • Conference paper
Rökan
  • 331 Accesses

Summary

The preferential tissue irrigatory effect of Ginkgo biloba extract in ischaemic areas is largely explained by the direct impact of this product on both arteries and veins.

The adrenergic vasoregulatory system and the vascular endothelium are the preferential targets for arterial impact. Ginkgo biloba extract reinforces the physiological vasoregulation of the sympathetic nervous system directly, by acting on neuromediator release, and indirectly, by inhibiting their extraneuronal degradation by catechol-orthomethyltransferase (C.O.M.T.).

In the arterial endothelium Ginkgo biloba extract stimulates the release of endogenous relaxing factors, such as endothelium-derived relaxing factor (EDRF) and prostacyclin.

The action of Ginkgo biloba extract on the venous system has been shown to have a venoconstrictor component that maintains the degree of parietal tonus essential to the dynamic clearing of toxic metabolites accumulated during tissue ischemia.

The originality of the vascular impact mechanisms of Ginkgo biloba extract is due to the fact that the product can at the same time combat the phenomena resulting from vascular spasm and with the same efficiency restore circulation in areas subject to vasomotor paralysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Auguet M., DeFeudis F.V., Clostre F., Deghenghi R.: Effects of an extract of Ginkgo biloba on rabbit isolated aport. Gen. Pharmac., 1982, 13, 225–230.

    Google Scholar 

  2. Auguet M., DeFeudis F.V., Clostre F., Deghenghi R.: Effects of Ginkgo biloba on arterial smooth muscle responses to vasoactive stimuli. Gen. Pharmac., 1982, 13, 169–171.

    Google Scholar 

  3. Auguet M., Clostre F.: Effects of an extract of Ginkgo biloba and diverse substances on the phasic and tonic components of the contraction of an isolated rabbit aorta. Gen. Pharmac., 1983, 14, 277–280.

    Article  CAS  Google Scholar 

  4. Auguet M., Hellegouarch A., Delaflotte S., Baranes J., DeFeudis F.V., Clostre F., Braquet P., Drieu K.: Effects of Ginkgo biloba extract on rabbit blood vessels. In: Cerebral ischemia, Bes A., Braquet P. Paoletti R., Siesjö B.K., Eds. Elsevier, Amsterdam, 1984, 347–354.

    Google Scholar 

  5. Baron J.: Phénomènes physiolpathologiques au cours del’ ischémie focale aiguë du cerveau. Revue de Médecine, 1983, 38, 1853–1863.

    Google Scholar 

  6. Bevan J.A.: Autonomic pharmacologist’s guide to the cerebral circulation. TIPS, 1984, 234–236.

    Google Scholar 

  7. Borchardt R.T., Huber J.A.: Catechol O-Methyltransferase-5 structure — activity relationships for inhibition by flavonoids. J. Med. Chem., 1975, 18, 120–122.

    Article  PubMed  CAS  Google Scholar 

  8. Borzeix M.G., Labos M., Hard C.: Recherches sur l’action anti-agrégante de l’extrait de Ginkgo biloba. Activité au niveau des artères et des veines de la pie-mère chez le lapin. Sem. Hôpitaux, 1980, 56, 383–398.

    Google Scholar 

  9. Chabrier P.E., Roubert P.: Capillaires cérébraux barrière hémato-encéphalique et effet de l’extrait de Ginkgo biloba. Presse Méd. 1986, 15, 1498–1501.

    PubMed  CAS  Google Scholar 

  10. Chatterjee S.S.: Effects of Ginkgo biloba extract on cerebral metabolic processes. In: Effects of Ginkgo biloba extract on organic cerebral impairment, Agnoli A., Rapin J.R., Scapagnini V. Weitbrecht W.V. eds, John Libbey, London, 1985, 5–15.

    Google Scholar 

  11. DeFeudis F.V., Auguet M., Delaflotte S., Hellegouarch A., Baranes J., Chapelat M., Braquet M., Etienne A., Drieu K., Clostre F., and Braquet P.: Some in vitro and in vivo actions of an extract of Ginkgo biloba (GBE U761). In: Effects of Ginkgo biloba extract on organic cerebral impairment, Agnoli A., Rapin J.R., Scapagnini V. Weitbrecht W.V. eds, John Libbey, London, 1985, 17–29.

    Google Scholar 

  12. DeFeudis F.V.: Mechanism of endothelium-dependent vasorelaxation. Medical Hypotheses,1985, 17,363–374.M. Auguet et al.

    Google Scholar 

  13. Delaflotte S., Auguet M., DeFeudis F.V., Baranes J., Clostre F., Drieu K., Braquet P.: Endothelium-dependent relaxations of rabbit isolated aorta produced by carbachol and by Ginkgo biloba extract. Biomed. Biochiin. Acta, 1984, 43, 5212–5216.

    Google Scholar 

  14. Edvisson L.: Vascular autonomic nerves and corresponding receptor in brain vessels. Path. Biol., 1982, 30, 261–268.

    Google Scholar 

  15. Etienne A., Hecquet F., Clostre F., DeFeudis F.V.: Comparaison des effets d’un extrait de Ginkgo biloba et de la chlorpromazine sur la fragilité osmotique, in vitro, d’érythrocytes de rat. J. Pharmacol. (Paris), 1982, 13, 291–298.

    CAS  Google Scholar 

  16. Forsterman V., Neufang B.: The endothelium-dependent vasodilator effect of acetylcholine: characterization of the endothelial relaxing factor with inhibitors of arachidonic acid metabolism. Eur. J. Pharmacol., 1984, 103, 65–70.

    Article  Google Scholar 

  17. Furchgott R.F., Zawadzki J.V.: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetyl-choline. Nature, 1980, 288, 373–376.

    Article  PubMed  CAS  Google Scholar 

  18. Furchgott R.F.: The role of endothelium in the responses of vascular smooth muscle to drugs. Ann. Rev. Pharmacol. Toxicol., 1984, 24, 175–197.

    Article  CAS  Google Scholar 

  19. Harik S.I.: Neurotransmitter receptors in cerebral microvessels. In: Neurotransmitters and the cerebral circulation. MacKenzie E.T., Seylaz J., Bes A. eds, Raven Press. New York, 1984, 1–9.

    Google Scholar 

  20. Herman A.G., Beetens J.R.: Effects of vasoactive substances on prostacycline synthesis. XV Bad Herrenalber angiologisches Gespräch 1983, 22–23 April, 83–87.

    Google Scholar 

  21. Keatinge W.R., Clare Harman M.: Local mechanisms controlling blood vessels. Academic Press inc, London, 1980.

    Google Scholar 

  22. Krahengühl B.: Vasodilatateurs dans les affections artérielles occlusives? Med. etHyg., 1982, 40, 171–172.

    Google Scholar 

  23. Larsen R.G., Dupeyron J.P., Boulu R.G.: Modèle d’ischémie cérébrale expérimentale par microsphères chez le rat. Etude de l’effet de deux extraits de Ginkgo biloba et du naftidrofuryl. Thérapie, 1978, 33, 651–660.

    PubMed  CAS  Google Scholar 

  24. Lassen N.A.: The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain. Lancet, 1966, 2, 1113–1115.

    Article  PubMed  CAS  Google Scholar 

  25. Le Poncin-Lafitte M., Rapin J., Rapin J.R.: Effect of Ginkgo biloba on changes induced by quantitative cerebral micro-embolization in rats. Arch. Int. Pharmacodyn., 1980, 243, 236–244.

    PubMed  Google Scholar 

  26. Morishita H.: Distribution and characterization of the adrenoceptors in dog coronary arteries. Arch. Int. Pharmacodyn., 1979, 239, 195–207.

    PubMed  CAS  Google Scholar 

  27. Mueller S.M., Heistad D.D., Marcus M.L.: Effect of the sympathetic nerves on cerebral vessels during seizures. Am. J. Physiol., 1979, 237, H178 - H184.

    PubMed  CAS  Google Scholar 

  28. Osswald W., Guimaraes S.: Adrenergic mechanisms in blood vessels: morphological and pharmacological aspects. Rev. Physiol. Biochem. Pharmacol., 1983, 96, 53–122.

    Article  PubMed  CAS  Google Scholar 

  29. Rapoport R.M., Murad F.: Endothelium-dependent and nitro-vasodilatorinduced relaxation of vascular smooth muscle: Role of cyclic GMP. J. Cyclic Nuc. Res., 1983, 9, 281–296.

    CAS  Google Scholar 

  30. Ruckstuhl M., Beretz A., Anton R., Landry Y.: Flavonoïds are selective cyclic GMP phosphodiesterase inhibitors. Biochem. Pharmac., 1979, 28. 535–538.

    Article  CAS  Google Scholar 

  31. Seylaz J.: Rôle du système nerveux autonome dans la régulation de la circulation sanguine cérébrale. Circ. et Métabolisme du Cerveau, 1985, 2, 115–132.

    Google Scholar 

  32. Spinnewyn B., Blavet N., Clostre F.: Effets du Ginkgo biloba sur l’ischémie cérébrale expérimentale chez la gerbille. Presse Méd., 1986, 15, 1511–1515.

    PubMed  CAS  Google Scholar 

  33. Vanhoutte P.M., Miller U.M.: Heterogeneity of endothelium-dependent responses in mammalian blood vessels. J. Cardiovasc. Pharmacol. 1985, 7, S 12 - S23.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg New York

About this paper

Cite this paper

Auguet, M., Delaflotte, S., Hellegouarch, A., Clostre, F. (1988). The Pharmacological Bases for the Vascular Impact of Ginkgo Biloba Extract. In: Fünfgeld, E.W. (eds) Rökan. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73686-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73686-5_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-19261-9

  • Online ISBN: 978-3-642-73686-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics